BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37154040)

  • 1. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
    Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study.
    Avdic T; Eliasson B; Rawshani A; Boren J; Gerstein HC; Nordanstig J; Rihawi M; Beckman JA; McGuire DK; Omerovic E; Sattar N; Bhatt DL; Rawshani A
    Lancet Reg Health Eur; 2024 Apr; 39():100852. PubMed ID: 38803631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk score.
    Lin Y; Shao H; Shi L; Anderson AH; Fonseca V
    Diabetes Obes Metab; 2022 Nov; 24(11):2203-2211. PubMed ID: 35801340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.
    de Simone G; Devereux RB; Roman MJ; Chinali M; Barac A; Panza JA; Lee ET; Galloway JM; Howard BV
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):285-91. PubMed ID: 21940153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J; Budoff MJ; Reilly MP; Yang W; Rosas SE; Rahman M; Zhang X; Roy JA; Lustigova E; Nessel L; Ford V; Raj D; Porter AC; Soliman EZ; Wright JT; Wolf M; He J;
    JAMA Cardiol; 2017 Jun; 2(6):635-643. PubMed ID: 28329057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    Rawshani A; Rawshani A; Franzén S; Sattar N; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; McGuire DK; Rosengren A; Gudbjörnsdottir S
    N Engl J Med; 2018 Aug; 379(7):633-644. PubMed ID: 30110583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
    Gerber Y; Weston SA; Enriquez-Sarano M; Manemann SM; Chamberlain AM; Jiang R; Roger VL
    JAMA Cardiol; 2016 May; 1(2):156-62. PubMed ID: 27437886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes Mellitus.
    Edqvist J; Rawshani A; Adiels M; Björck L; Lind M; Svensson AM; Gudbjörnsdottir S; Sattar N; Rosengren A
    J Am Heart Assoc; 2019 Dec; 8(24):e013871. PubMed ID: 31818213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.
    Kawabe A; Yasu T; Morimoto T; Tokushige A; Momomura SI; Sakakura K; Node K; Inoue T; Ueda S;
    ESC Heart Fail; 2021 Oct; 8(5):3748-3759. PubMed ID: 34268904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
    Kristófi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nyström T; Norhammar A; Eriksson JW
    Cardiovasc Diabetol; 2022 Dec; 21(1):282. PubMed ID: 36522650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
    Patel KV; Bahnson JL; Gaussoin SA; Johnson KC; Pi-Sunyer X; White U; Olson KL; Bertoni AG; Kitzman DW; Berry JD; Pandey A;
    Circulation; 2020 Dec; 142(25):2420-2430. PubMed ID: 33164570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
    Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
    Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    Fisher DP; Johnson E; Haneuse S; Arterburn D; Coleman KJ; O'Connor PJ; O'Brien R; Bogart A; Theis MK; Anau J; Schroeder EB; Sidney S
    JAMA; 2018 Oct; 320(15):1570-1582. PubMed ID: 30326126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
    McAlister FA; Zheng Y; Westerhout CM; Buse JB; Standl E; McGuire DK; Van de Werf F; Green JB; Armstrong PW; Holman RR;
    Eur J Heart Fail; 2020 Nov; 22(11):2026-2034. PubMed ID: 32621557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study.
    Rawshani A; Eliasson B; Boren J; Sattar N; Bhatt D; El-Khalili L; Nordanstig J; Avdic T; Beckman JA; Gerstein HC; McGuire DK; Omerovic E; Rawshani A
    Lancet Reg Health Eur; 2024 Apr; 39():100888. PubMed ID: 38803635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
    Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
    Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
    Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities).
    Gupta DK; Skali H; Claggett B; Kasabov R; Cheng S; Shah AM; Loehr LR; Heiss G; Nambi V; Aguilar D; Wruck LM; Matsushita K; Folsom AR; Rosamond WD; Solomon SD
    JACC Heart Fail; 2014 Oct; 2(5):447-54. PubMed ID: 25194293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.